A Study of ASP1948, Targeting an Immune Modulatory Receptor, in Subjects With Advanced Solid Tumors

Condition:   Advanced Solid Tumors
Intervention:   Drug: ASP1948
Sponsors:   Astellas Pharma Global Development, Inc.;   Potenza Therapeutics
Not yet recruiting

https://ift.tt/2MFojAZ